News | March 23, 2022
Thyssenkrupp bags order for a pharma-grade SFE plant for solids extraction
The scope of supply includes the skid-mounted plant as well as on-site installation and commissioning support
The scope of supply includes the skid-mounted plant as well as on-site installation and commissioning support
Moving well beyond the traditional approach of testing a vaccine’s collective response in large populations, this precision approach can identify how an individual’s own immune system responds to a vaccine, offering an unprecedented opportunity to measure vaccine safety and effectiveness
First and only FDA-approved treatment for seizures associated with CDKL5 deficiency disorder (CDD) in patients two years of age and older
Innovative TIMScore for dda-PASEF and dia-PASEF libraries, combined with TIMS DIA-NN identifies 9000 protein groups from 200 ng K562 lysate in just 35 min gradient
If approved, PreHevbri will be the only approved 3-antigen hepatitis B vaccine for adults in the E.U.
These programs are: Herpes simplex virus (HSV) vaccine candidate, Varicella-zoster virus (VZV) vaccine candidate and Checkpoint cancer vaccine.
Apexxnar is the first pneumococcal conjugate vaccine to help protect adults ages 18 years and older against 20 serotypes responsible for the majority of invasive disease and pneumococcal pneumonia
KEYTRUDA is now approved as monotherapy for adults with Renal Cell Carcinoma (RCC)
First launches expected in H1 2022
Innovative market development collaboration also signed, expanding the availability of select Novartis oncology products in regions across China currently not covered by Novartis
Subscribe To Our Newsletter & Stay Updated
